Financials data is unavailable for this security.
View more
Year on year Sanofi India Ltd had little change in net income (from 6.21bn to 6.03bn). Revenues were also little changed (from 27.70bn to 28.51bn.)
| Gross margin | 53.94% |
|---|---|
| Net profit margin | 16.43% |
| Operating margin | 23.84% |
| Return on assets | -- |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in INRView more
In 2023, cash reserves at Sanofi India Ltd fell by 6.10bn. However, the company earned 2.30bn from its operations for a Cash Flow Margin of 8.08%. In addition the company generated 375.00m cash from investing, though they paid out 8.78bn more in financing than they received.
| Cash flow per share | 172.55 |
|---|---|
| Price/Cash flow per share | 35.99 |
| Book value per share | -- |
|---|---|
| Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
| Current ratio | -- |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
Growth rates in INR
Year on year, both dividends per share and earnings per share excluding extraordinary items growth dropped -13.92% and -2.85%, respectively. Additionally when measured on a five year annualized basis, both dividend per share and earnings per share growth ranked in-line with the industry average relative to its peers.
| Div yield(5 year avg) | 3.62% |
|---|---|
| Div growth rate (5 year) | 14.73% |
| Payout ratio (TTM) | 74.83% |
| EPS growth(5 years) | 9.64 |
|---|---|
| EPS (TTM) vs TTM 1 year ago | -31.38 |
More ▼
